Skip to content

Effect of cutting the most caudal lung branch nerve and filled the residual cavity after lymph node dissection using absorbable hemostatic yarn on chronic cough after radical lung cancer: a multi-center randomized trial of single-blind control 2 * 2 factorial design

Effect of cutting the most caudal lung branch nerve and filled the residual cavity after lymph node dissection using absorbable hemostatic yarn on chronic cough after radical lung cancer: a multi-center randomized trial of single-blind control 2 * 2 factorial design

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065805
Enrollment
Unknown
Registered
2022-11-15
Start date
2022-11-21
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic cough after lung cancer surgery

Interventions

A:cutting the most caudal lung branch nerve and filled the residual cavity after lymph node dissection using absorbable hemostatic yarn
B:preserved the most caudal lung branch nerve and filled the residual cavity after lymph node dissection using absorbable hemostatic yarn
C:cutting the most caudal lung branch nerve and not filled the residual cavity after lymph node dissection using absorbable hemostatic yarn
D:preserved the most caudal lung branch nerve and not filled the residual cavity after lymph node dissection using absorbable hemostatic yarn

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. ASA grade I-III; 2. Aged >= 18 years, male and female is unlimited; 3. Adult patients with elective thoracoscopic lobectomy and lymphadenectomy; and preoperative imaging findings of peripheral bronchopulmonary cancer, maximum diameter of <= 5cm (T<=2), no regional lymph node involvement (N0) or ipsilateral peribronchial lymph nodes and ipsilateral hilar lymph node involvement (N1), no evidence of distant metastasis (M0); 4. Consent was to participate in this study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. History of chronic cough, such as chronic bronchitis, asthma, gastroesophageal reflux disease, and retronasal drip syndrome; 2. Use of an angiotensin-converting enzyme inhibitor (ACEI); 3. Severe arrhythmia; 4. Previous history of thoracic surgery; 5. Simple lung wedge resection or lobectomy combined with a wedge resection is required; 6. See obvious chest adhesion during surgery; (Note: the adhesion area exceeds a single lung lobe or the cumulative adhesion area reaches 30% or more of the lung surface area); 7. Patients undergoing preoperative neoadjuvant therapy; 8. Preoperative chest CT measurements were the mediastinal lymph nodes greater than 10mm; 9. Previous history of tuberculosis or tuberculous pleurisy; 10. The intraoperative rapid freezing pathology reported the results as benign.

Design outcomes

Primary

MeasureTime frame
The incidence of chronic cough;

Secondary

MeasureTime frame
The incidence of cough;Pulmonary function index;postoperative complications ;Tumor classification and stage, and the number and size of dissected lymph nodes in the pathological results;cough CSS score;Visual Analogu Scale score;LCQ-MC score;

Countries

China

Contacts

Public ContactHao Zhang

The Affiliated Hospital of Xuzhou Medical University

haozhang-xz@163.com+86 17798835177

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026